163 related articles for article (PubMed ID: 29861627)
1.
Li C; Zou H; Wang Z; Tang X; Fan X; Zhang K; Liu J; Li Z
Drug Des Devel Ther; 2018; 12():1363-1371. PubMed ID: 29861627
[TBL] [Abstract][Full Text] [Related]
2. Expression of REST4 in human gliomas in vivo and influence of pioglitazone on REST in vitro.
Ren H; Gao Z; Wu N; Zeng L; Tang X; Chen X; Liu Z; Zhang W; Wang L; Li Z
Biochem Biophys Res Commun; 2015 Aug; 463(4):504-9. PubMed ID: 26003726
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms and potential prognostic effects of REST and REST4 in glioma (Review).
Li C; Wang Z; Tang X; Zeng L; Fan X; Li Z
Mol Med Rep; 2017 Oct; 16(4):3707-3712. PubMed ID: 29067465
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of mouse repressor element-1 silencing transcription factor 4 (REST4) and its possible function in neuroblastoma.
Lee JH; Chai YG; Hersh LB
J Mol Neurosci; 2000 Dec; 15(3):205-14. PubMed ID: 11303784
[TBL] [Abstract][Full Text] [Related]
5. RE-1 silencing transcription factor-4 (REST4) is neither a transcriptional repressor nor a de-repressor.
Magin A; Lietz M; Cibelli G; Thiel G
Neurochem Int; 2002 Mar; 40(3):195-202. PubMed ID: 11741002
[TBL] [Abstract][Full Text] [Related]
6. REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activation.
Tabuchi A; Yamada T; Sasagawa S; Naruse Y; Mori N; Tsuda M
Biochem Biophys Res Commun; 2002 Jan; 290(1):415-20. PubMed ID: 11779185
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST.
Shimojo M; Paquette AJ; Anderson DJ; Hersh LB
Mol Cell Biol; 1999 Oct; 19(10):6788-95. PubMed ID: 10490617
[TBL] [Abstract][Full Text] [Related]
8. Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models.
Spencer EM; Chandler KE; Haddley K; Howard MR; Hughes D; Belyaev ND; Coulson JM; Stewart JP; Buckley NJ; Kipar A; Walker MC; Quinn JP
Neurobiol Dis; 2006 Oct; 24(1):41-52. PubMed ID: 16828291
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Expression of Rest4 Gene in Low-Functioning Pancreatic Beta Cell Line.
Yamato E
Horm Metab Res; 2023 Jun; 55(6):426-431. PubMed ID: 36758614
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cholinergic gene expression by the neuron restrictive silencer factor/repressor element-1 silencing transcription factor.
Hersh LB; Shimojo M
Life Sci; 2003 Mar; 72(18-19):2021-8. PubMed ID: 12628452
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
12. Studies on the interaction of REST4 with the cholinergic repressor element-1/neuron restrictive silencer element.
Lee JH; Shimojo M; Chai YG; Hersh LB
Brain Res Mol Brain Res; 2000 Aug; 80(1):88-98. PubMed ID: 11039732
[TBL] [Abstract][Full Text] [Related]
13. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
McDuff SGR; Dietrich J; Atkins KM; Oh KS; Loeffler JS; Shih HA
Cancer Med; 2020 Jan; 9(1):3-11. PubMed ID: 31701682
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
[TBL] [Abstract][Full Text] [Related]
15. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
[TBL] [Abstract][Full Text] [Related]
16. HuB/C/D, nPTB, REST4, and miR-124 regulators of neuronal cell identity are also utilized in the lens.
Bitel CL; Perrone-Bizzozero NI; Frederikse PH
Mol Vis; 2010 Nov; 16():2301-16. PubMed ID: 21139978
[TBL] [Abstract][Full Text] [Related]
17. TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas.
Chen C; Han S; Meng L; Li Z; Zhang X; Wu A
PLoS One; 2014; 9(6):e100297. PubMed ID: 24937153
[TBL] [Abstract][Full Text] [Related]
18. Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents.
Uchida S; Hara K; Kobayashi A; Funato H; Hobara T; Otsuki K; Yamagata H; McEwen BS; Watanabe Y
J Neurosci; 2010 Nov; 30(45):15007-18. PubMed ID: 21068306
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of two regimens of postoperative concurrent chemoradiotherapy in adult patients with grade III-IV cerebral gliomas].
Zhai X; Wang J; Zhang J; Gu K
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):255-7. PubMed ID: 22381771
[TBL] [Abstract][Full Text] [Related]
20. Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma.
Sirachainan N; Pakakasama S; Visudithbhan A; Chiamchanya S; Tuntiyatorn L; Dhanachai M; Laothamatas J; Hongeng S
Neuro Oncol; 2008 Aug; 10(4):577-82. PubMed ID: 18559468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
